BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 30201690)

  • 1. Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells.
    Chen WX; Xu LY; Qian Q; He X; Peng WT; Zhu YL; Cheng L
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30201690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs.
    Mao L; Li J; Chen WX; Cai YQ; Yu DD; Zhong SL; Zhao JH; Zhou JW; Tang JH
    Tumour Biol; 2016 Apr; 37(4):5247-56. PubMed ID: 26555545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
    Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
    PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
    Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics analysis of dysregulated microRNAs in exosomes from docetaxel-resistant and parental human breast cancer cells.
    Chen WX; Xu LY; Cheng L; Qian Q; He X; Peng WT; Zhu YL
    Cancer Manag Res; 2019; 11():5425-5435. PubMed ID: 31354350
    [No Abstract]   [Full Text] [Related]  

  • 6. miRNA expression patterns in chemoresistant breast cancer tissues.
    Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
    Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression.
    Zhou S; Li J; Xu H; Zhang S; Chen X; Chen W; Yang S; Zhong S; Zhao J; Tang J
    Gene; 2017 Jul; 622():1-12. PubMed ID: 28431975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.
    Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH
    Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of microRNAs expressed in human breast cancer chemo-resistant MCF-7/Adr cells by Solexa deep-sequencing technology.
    Xu P; Wang L; Huang L; Li W; Lv S; Lv M; Ma J; Zhou Q; Wu X; Fu Z; Lu C; Yin H
    Biomed Pharmacother; 2015 Oct; 75():173-8. PubMed ID: 26293775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes.
    Zhong S; Chen X; Wang D; Zhang X; Shen H; Yang S; Lv M; Tang J; Zhao J
    Oncotarget; 2016 Apr; 7(15):19601-9. PubMed ID: 26910922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis.
    Zhao X; Ren Y; Cui N; Wang X; Cui Y
    Medicine (Baltimore); 2018 Sep; 97(39):e12632. PubMed ID: 30278585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatic identification of chemoresistance-associated microRNAs in breast cancer based on microarray data.
    Wang YW; Zhang W; Ma R
    Oncol Rep; 2018 Mar; 39(3):1003-1010. PubMed ID: 29328395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
    Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
    Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d Rhamnose β-hederin reverses chemoresistance of breast cancer cells by regulating exosome-mediated resistance transmission.
    Chen WX; Xu LY; Qian Q; He X; Peng WT; Fan WQ; Zhu YL; Tang JH; Cheng L
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer.
    Wang X; Xu C; Hua Y; Sun L; Cheng K; Jia Z; Han Y; Dong J; Cui Y; Yang Z
    J Exp Clin Cancer Res; 2016 Dec; 35(1):186. PubMed ID: 27906043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic PM
    Xu Z; Wang N; Xu Y; Hua L; Zhou D; Zheng M; Deng X
    Toxicol Lett; 2019 Nov; 316():49-59. PubMed ID: 31520698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.